ATNF

180 Life Sciences Corporation
3.3386
-0.0614 (-1.81%)

180 Life Sciences Corp. (ATNF) Fundamentals

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.
SHARE INFORMATION
Market Cap$ 86,132,000
Shares Outstanding24,400,000
Float3,519,455
Percent Float14.42%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -21.00
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions49
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months41,501
Institutional Holdings Percent4.2%
Institutional Sold Previous 3 Months191,175
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months142,551
Insider Holdings Percent10.9
Insider Sold Previous 3 Months-
Insider Shares Owned4,399,618
TRADING INFO
52 Week High$ 7.15
52 Week Low$ 0.16
52 Week High Change$ 3.82
21 Day Moving Average$ 3.79
21 Day Extended Moving Average$ 3.3822
50 Day Moving Average$ 2.2865
50 Day Extended Moving Average$ 2.6388
200 Day Moving Average$ 1.3057
200 Day Extended Moving Average$ 1.9616
10 Day Average Volume3,115,251
20 Day Average Volume2,854,956
30 Day Average Volume7,979,140
50 Day Average Volume5,481,409
Alpha0.110527
Beta-2.4376
Standard Deviation0.945633
R20.019387
7 Day Price Change$ 0.29
7 Day Percent Change8.95%
21 Day Price Change$ -0.18
21 Day Percent Change-4.85%
30 Day Price Change$ -1.77
30 Day Percent Change-33.4%
Month to Date Price Change$ 0.20
Month to Date Percent Change6.01%
Quarter to Date Price Change$ 0.14
Quarter to Date Percent Change4.13%
180 Day Price Change$ 2.31
180 Day Percent Change189.34%
200 Day Price Change$ 2.42
200 Day Percent Change218.02%
Year to Date Price Change$ 0.14
Year to Date Percent Change4.13%

180 Life Sciences Corp. (ATNF) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-7.60
Total Debt To Equity0.00
Int Coverage-449.50
Current Ratio1.40
Leverage Ratio1.30
Quick Ratio1.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.50
Enterprise Value$ 10,042,040
Price to Sales0.00
Price to Free Cash-1.40
PE High Last 5 Years0.00
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-7.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-32.09
Return on Equity-50.45
Return on Capital-49.67

180 Life Sciences Corp. (ATNF) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMarcum LLP
CEOJames N. Woody
Emplyoees7
Last AuditUE
CIK0001690080
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address3000 El Camino Real, Bldg. 4
Suite 100
Palo Alto, CA 94306
Websitehttps://www.180lifesciences.com
Facsimile-
Telephone+1 650 507-0669
Email-


Your Recent History
NASDAQ
ATNF
180 Life S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.